Gilead Sciences Surpasses Analyst Target: What’s Next for Investors?
Recently, shares of Gilead Sciences Inc (Symbol: GILD) have risen above the average 12-month analyst target price of $85.46, trading at $85.83 per share. When a stock meets its target, analysts typically must decide how to respond: either downgrade their valuation or adjust their target price higher. Their decision may depend on how recent changes in the company’s fundamentals have contributed to the stock’s increase.
The Zacks coverage universe offers insights from 24 different analysts regarding Gilead Sciences Inc. While the average price target reflects a collective perspective, it is essential to recognize the range of individual predictions. For example, one analyst sets a target as low as $69.00, while another predicts a high of $123.00. Notably, the standard deviation among these targets is $12.72, indicating a variety of opinions.
Investors often look at the average price target to assess a broader sentiment, rather than relying on a single expert’s view. With GILD crossing above the average target price of $85.46 per share, current investors should evaluate if this level is merely a stepping stone toward an even higher target or if it signals that the stock’s valuation is becoming overextended. Below is the latest analysis from those covering Gilead Sciences Inc:
| Recent GILD Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| » | Current | 1 Month Ago | 2 Month Ago | 3 Month Ago |
| Strong buy ratings: | 13 | 12 | 12 | 11 |
| Buy ratings: | 1 | 1 | 1 | 1 |
| Hold ratings: | 12 | 13 | 13 | 13 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.96 | 2.04 | 2.04 | 2.08 |
The average rating displayed in the last row of the table is on a scale from 1 to 5, where 1 equals Strong Buy and 5 equals Strong Sell. This information is sourced from Zacks Investment Research through Quandl.com. For the latest Zacks research report on GILD — FREE.
Explore the Top 25 Broker Analyst Picks of the S&P 500 »
Also see:
• OSPR YTD Return
• DPRO Average Annual Return
• AXL YTD Return
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
